HuagongsheHuagongshe Chemistry Print Report · For research reference only
Benzimidazole → N-[(5S)-3-(3-Fluoro-4-(4-benzimidazol-1-ylmethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-ylmethyl]acetamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Benzimidazole | HCID 5798 | — |
| Reactant | 1,1-Bis(2,2-dimethylpropoxy)-N,N-dimethylmethanamine | HCID 78623 | — |
| Reactant | N-[(5S)-3-(3-Fluoro-4-(4-hydroxymethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-yl-methyl]acetamide | HCID 10760118 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | N-[(5S)-3-(3-Fluoro-4-(4-benzimidazol-1-ylmethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-ylmethyl]acetamide | HCID 70153513 | 37.3% |
Reaction Steps
N-[(5S)-3-(3-Fluoro-4-(4-hydroxymethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-yl-methyl]acetamide (104 mg, 0.3 mM) and benzimidazole (71 mg, 0.6 mM) were suspended in dry acetonitrile (6 ml) under argon, and NAN-dimethylformamide dineopentyl acetal (208 mg, 0.9 mM) added. The mixture was refluxed for 8 hours. Solvent was evaporated, and the residue dissolved in dichloromethane and chrornatographed on a 10 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 20% methanol in dichnoromethane. Relevant fractions were combined and evaporated to give the title product (50 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06495551B1 |
| Source dataset | uspto-grants-2002_12 |
| ORD ID | ord-f88d095bb2c04c7eacfa54f5a29922b2 |
| Source note | uspto-grants-2002_12 |